Search results for "target"

showing 10 items of 1196 documents

Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine

2012

Neutrophil gelatinase-associated lipocalin (NGAL, a.k.a Lnc2) is a member of the lipocalin family and has diverse roles. NGAL can stabilize matrix metalloproteinase-9 from autodegradation. NGAL is considered as a siderocalin that is important in the transport of iron. NGAL expression has also been associated with certain neoplasias and is implicated in the metastasis of breast cancer. In a previous study, we examined whether ectopic NGAL expression would alter the sensitivity of breast epithelial, breast and colorectal cancer cells to the effects of the chemotherapeutic drug doxorubicin. While abundant NGAL expression was detected in all the cells infected with a retrovirus encoding NGAL, t…

BenzylaminesBerberinemedicine.medical_treatmentDrug ResistanceGene ExpressionBCL-2; Berberine; Breast cancer; Calmodulin kinase; Colorectal cancer; EGFR; Inhibitor sensitivity; Lcn2; Lipocalins; NGAL; Rapamycin; Siderocalins; Targeted therapyPiperazinesMetastasisTargeted therapyNitrophenolsTargeted therapyBreast cancerAntibioticsNGALSulfonamidesAntibiotics AntineoplasticTumorSiderocalinsTyrphostinsAntineoplasticLipocalinsBiphenyl compoundErbB ReceptorsProto-Oncogene Proteins c-bcl-2MCF-7 CellsFemalelipocalinHT29 Cellsmedicine.drugbcl-2; breast cancer; lipocalins; targeted therapy; berberine; lcn2; colorectal cancer; rapamycin; inhibitor sensitivity; siderocalins; egfr; ngal; calmodulin kinaseCalmodulin kinasesiderocalinEGFRBCL-2Breast NeoplasmsSiderocalinBiologyNGAL Lcn2 lipocalins siderocalins targeted therapy inhibitor sensitivity EGFR rapamycin berberine BCL-2 calmodulin kinase breast cancer colorectal cancerCell LineHT29 CellsLcn2Lipocalin-2ReportCell Line TumorProto-Oncogene ProteinsmedicineHumansDoxorubicinRapamycinMolecular BiologyProtein Kinase InhibitorsSirolimusBiphenyl CompoundsCell Biologymedicine.diseaseColorectal cancerCell cultureDoxorubicinDrug Resistance NeoplasmCancer cellCalcium-Calmodulin-Dependent Protein KinasesCancer researchQuinazolinesNeoplasmInhibitor sensitivityDevelopmental BiologyAcute-Phase Proteins
researchProduct

GSK-3? Can Regulate the Sensitivity of MIA-PaCa-2 Pancreatic and MCF-7 Breast Cancer Cells to Chemotherapeutic Drugs, Targeted Therapeutics and Nutra…

2021

Glycogen synthase kinase-3 (GSK-3) is a regulator of signaling pathways. KRas is frequently mutated in pancreatic cancers. The growth of certain pancreatic cancers is KRas-dependent and can be suppressed by GSK-3 inhibitors, documenting a link between KRas and GSK-3. To further elucidate the roles of GSK-3β in drug-resistance, we transfected KRas-dependent MIA-PaCa-2 pancreatic cells with wild-type (WT) and kinase-dead (KD) forms of GSK-3β. Transfection of MIA-PaCa-2 cells with WT-GSK-3β increased their resistance to various chemotherapeutic drugs and certain small molecule inhibitors. Transfection of cells with KD-GSK-3β often increased therapeutic sensitivity. An exception was observed wi…

Berberineendocrine system diseasesmedicine.medical_treatmentRegulatormedicine.disease_causeDeoxycytidinePiperazinesTargeted therapychemotherapeutic drugsTargeted therapyNitrophenolsBreast cancerGSK-3BGlycolysisMolecular Targeted TherapyNeoplasm Metastasistargeted therapy;lcsh:QH301-705.5Tumor Stem Cell AssaySulfonamidesTumorbiologyChemistryGeneral MedicineTransfectionMetforminDisease ProgressionMCF-7 CellsFemaleKRASNutraceuticalsFluorouracilSignal transductionGlycolysisSignal TransductionBCL2bcl-X ProteinAntineoplastic AgentsBreast Neoplasmsmacromolecular substancesAdenocarcinomaArticleCell LineInhibitory Concentration 50Cell Line TumorThiadiazolesmedicineDiabetes MellitusKRasHumansGlycogen synthaseProtein Kinase InhibitorsCell ProliferationChemotherapeu-tic drugsGlycogen Synthase Kinase 3 betaGSK-3βAdenylate KinaseBiphenyl Compoundsnutraceuticals;PDACβ-cateninGemcitabine?-cateninMalariaPancreatic Neoplasmslcsh:Biology (General)MCF-7DoxorubicinDietary SupplementsCancer researchbiology.protein
researchProduct

Digitālo mediju ietekme uz lēmumu pieņemšanu un demokrātiju

2018

Mūsdienās tādu tehnoloģiju progress kā mākslīgais intelekts apvienojumā ar Lielo Datu analīzi ir devis iespēju ievākt, uzturēt un analizēt milzīgus datu apjomus. Progress digitālajā jomā ietekmē ne tikai tirgus ekonomiku, bet arī politisko līdzdalību. Digitālie mediji spēj apvienot līdzīgi domājošos, iedrošināt sociālas aktivitātes, mazināt plaisas starp sabiedrības grupām, kā arī paaugstināt politisko līdzdalību valstī un veicināt izglītību, tomēr ir pastiprinātas bažas par to, ka digitālo mediju platformas var tikt izmantotas, lai izplatītu propagandas vēstījumus, kas is spējīga piesaistīt lielu auditoriju. Automātiskajiem filtrēšanas mehānismiem var piemist diskriminējošs raksturs, ietek…

Big DataEkonomikadecision-makingmircrotargetingdigital mediafilter bubbles
researchProduct

Fiscal Adjustment and Business Cycle Synchronization

2013

Using a panel of annual data for 20 countries we show that synchronized fiscal consolidation (stimulus) programmes in different countries make their business cycles more closely linked, especially in the case of fiscal adjustments lasting 2 or 3 years. We also find: (i) little evidence of decoupling when an inflation targeting regime is unilaterally adopted; (ii) an increase in business cycle synchronization when countries fix their exchange rates and become members of a monetary union; (iii) a positive effect of bilateral trade on the synchronization of business cycles.

Bilateral tradeStimulus (economics)Consolidation (business)jel:C41Inflation targetingjel:E62EconomicsBusiness cycleMonetary economicsBusiness cycle synchronizationFiscal consolidation fiscal stimulus business cycle synchronizationSSRN Electronic Journal
researchProduct

Recent advances in smart biotechnology: Hydrogels and nanocarriers for tailored bioactive molecules depot

2017

Over the past ten years, the global biopharmaceutical market has remarkably grown, with ten over the top twenty worldwide high performance medical treatment sales being biologics. Thus, biotech R&D (research and development) sector is becoming a key leading branch, with expanding revenues. Biotechnology offers considerable advantages compared to traditional therapeutic approaches, such as reducing side effects, specific treatments, higher patient compliance and therefore more effective treatments leading to lower healthcare costs. Within this sector, smart nanotechnology and colloidal self-assembling systems represent pivotal tools able to modulate the delivery of therapeutics. A comprehens…

Bioactive molecules02 engineering and technologyHepatocellular-carcinoma cells01 natural sciencesMiceColloid and Surface ChemistryDrug Delivery SystemsCarbon nano materialNanotechnologyMolecular Targeted TherapyTransgenesRNA Small InterferingPatient complianceTransfer radical polymerizationMicro/nanocarrierMedical treatmentMicro/nanocarriersBioactive molecule deliveryHydrogelsSurfaces and Interfaces021001 nanoscience & nanotechnologyLiposomeBiopharmaceuticalOral deliverySelf-healing hydrogelsIntercellular Signaling Peptides and Proteins0210 nano-technologyAssembling peptide hydrogelsSurfaces and InterfaceNucleic-acid deliveryPlasmidsDiagnostic ImagingSolid lipid nanoparticlesNanotechnology010402 general chemistryAntibodiesSmall Molecule LibrariesCarbon nano-onionsIn-vivoAnimalsHumansPhysical and Theoretical Chemistrybusiness.industryDrug-delivery0104 chemical sciencesBiotechnologyHydrogelSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoMolecular ProbesBioactive molecule delivery; Carbon nano materials; Hydrogels; Liposomes; Micro/nanocarriers; Surfaces and Interfaces; Physical and Theoretical Chemistry; Colloid and Surface ChemistryLiposomesNonviral gene deliveryCarbon nano materialsNanoparticlesBusinessNanocarriers
researchProduct

Design, characterization and in vitro evaluation of 5-aminosalicylic acid loaded N-succinyl-chitosan microparticles for colon specific delivery

2011

The objective of this study was to prepare NS-chitosan microparticles for the delivery of 5-aminosalicylic acid (5-ASA) to the colon. Microparticles can spread out over a large area of colon allowing a more effective local efficacy of 5-ASA. N-Succinyl-chitosan was chosen as carrier system because of its excellent pharmaceutical properties in colon drug targeting such as poor solubility in acid environment, biocompatibility, mucoadhesive properties, and low toxicity. It was prepared by introducing succinic group into chitosan N-terminals of the glucosamine units. 5-ASA loaded NS-chitosan microparticles were prepared using spray-drying. As a control, a matrix obtained by freeze-drying techni…

BiocompatibilityCarrier systemColonStatic ElectricityBiocompatible MaterialsNanotechnologyChitosanchemistry.chemical_compoundDrug Delivery SystemsColloid and Surface ChemistryDifferential scanning calorimetryX-Ray DiffractionSpectroscopy Fourier Transform InfraredmedicineZeta potentialHumansDesiccationParticle SizePhysical and Theoretical ChemistrySolubilityMesalamineChitosanCalorimetry Differential ScanningSurfaces and InterfacesGeneral MedicineHydrogen-Ion ConcentrationMicrospheresKineticsFreeze DryingSolubilitychemistryTargeted drug deliveryMicroscopy Electron ScanningWettabilitySwellingmedicine.symptomRheologyBiotechnologyNuclear chemistryColloids and Surfaces B: Biointerfaces
researchProduct

1,5-Disubstituted 1,2,3-Triazoles as Amide Bond Isosteres Yield Novel Tumor-Targeting Minigastrin Analogs.

2021

[Image: see text] 1,5-Disubstituted 1,2,3-triazoles (1,5-Tz) are considered bioisosteres of cis-amide bonds. However, their use for enhancing the pharmacological properties of peptides or proteins is not yet well established. Aiming to illustrate their utility, we chose the peptide conjugate [Nle(15)]MG11 (DOTA-dGlu-Ala-Tyr-Gly-Trp-Nle-Asp-Phe-NH(2)) as a model compound since it is known that the cholecystokinin-2 receptor (CCK2R) is able to accommodate turn conformations. Analogs of [Nle(15)]MG11 incorporating 1,5-Tz in the backbone were synthesized and radiolabeled with lutetium-177, and their pharmacological properties (cell internalization, receptor binding affinity and specificity, pla…

Biodistribution3-TriazolesStereochemistryPeptidomimeticmedia_common.quotation_subject1201 natural sciencesBiochemistryTurn (biochemistry)Drug Discovery[CHIM]Chemical SciencesPeptide bondInternalizationReceptorCancermedia_commonTumor Targeting[CHIM.ORGA]Chemical Sciences/Organic chemistry010405 organic chemistryChemistry123-Triazoles; Peptidomimetics; Structure−activity relationships; Radiopharmaceuticals; Tumor targeting; CancerStructure-Activity RelationshipsOrganic ChemistryBiological activity0104 chemical sciences010404 medicinal & biomolecular chemistryYield (chemistry)PeptidomimeticsRadiopharmaceuticalsACS medicinal chemistry letters
researchProduct

Bisphosphonate-polyaspartamide conjugates as bone targeted drug delivery systems.

2015

Poly-hydroxy-aspartamide was used as a backbone to synthesize bisphosphonate derivatives thus achieving macromolecular carriers to be potentially used as targeting agents for bone drug delivery. Molecules bearing bisphosphonate groups, such as aminobisphosphonate (ABP) and neridronate (NRD), have been conjugated to polyaspartamide (α,β-poly(N-2-hydroxyethyl)-dl-aspartamide, PHEA), with or without a spacer (succinic acid or 6-aminocaproic acid) thus obtaining PHEA-succinate-ABP and PHEA-caproylcarbamate-ABP and PHEA-ABP and PHEA-NRD, respectively. Bisphosphonate-polymer conjugates were physico-chemically characterized using size exclusion chromatography and 1H-NMR; and their in vitro and e…

BiodistributionMaterials scienceMedicine (all)medicine.medical_treatmentChemistry (all)Biomedical EngineeringGeneral ChemistryGeneral MedicineBisphosphonateBone tissueIn vitromedicine.anatomical_structureBiochemistryTargeted drug deliverySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoIn vivoDrug deliverymedicineGeneral Materials ScienceMaterials Science (all)Ex vivoJournal of materials chemistry. B
researchProduct

Effect of endothelial cell heterogeneity on nanoparticle uptake.

2020

Endothelial cells exhibit distinct properties in morphology and functions in different organs that can be exploited for nanomedicine targeting. In this work, endothelial cells from different organs, i.e. brain, lung, liver, and kidney, were exposed to plain, carboxylated, and amino-modified silica. As expected, different protein coronas were formed on the different nanoparticle types and these changed when foetal bovine serum (FBS) or human serum were used. Uptake efficiencies differed strongly in the different endothelia, confirming that the cells retained some of their organ-specific differences. However, all endothelia showed higher uptake for the amino-modified silica in FBS, but, inter…

Biodistributionmedia_common.quotation_subjectReceptor expressionEndothelial cellsBristol Heart InstitutePharmaceutical ScienceUptake02 engineering and technologyADHESIONBlood–brain barrier030226 pharmacology & pharmacySERUM03 medical and health sciencesDELIVERY0302 clinical medicineBIODISTRIBUTIONmedicineHumansBovine serum albuminInternalization/dk/atira/pure/core/keywords/heart_SRImedia_commonchemistry.chemical_classificationKidneyPROTEIN-CORONAbiologyChemistryBLOOD-BRAIN-BARRIEREndothelial CellsBiological Transportrespiratory system021001 nanoscience & nanotechnologyCell biologyEndothelial stem cellSURFACE-CHARGEmedicine.anatomical_structureSIZENanomedicineTransferrinProtein coronabiology.proteinINTERNALIZATIONNanoparticlesProtein CoronaHeterogeneityMEMBRANE0210 nano-technologyEndothelial cell targetingInternational journal of pharmaceutics
researchProduct

NOVEL COMPOSED GALACTOSYLATED NANODEVICES CONTAINING A RIBAVIRIN PRODRUG AS HEPATIC CELL-TARGETED CARRIERS FOR HCV TREATMENT

2013

In this paper, we describe the preparation of liver-targeted nanoparticles potentially able to carry to hepatocytes a ribavirin (RBV) prodrug, exploiting the presence of carbohydrate receptors in the liver (i.e., ASGPR in hepatocytes). These particles were obtained starting from a galactosylated phospholipid-polyaminoacid conjugate. This latter was obtained by chemical reaction of ALPHA, BETA -poly(N-2-hydroxyethyl) (2-aminoethylcarbamate)-DL-aspartamide (PHEA-EDA) with 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(succinyl) sodium salt (DPPE), and subsequent reaction with lactose, obtaining PHEA-EDA-DPPE-GAL copolymer. To enhance the entrapment into obtained nanostructures, a hydroph…

Biomedical EngineeringPharmaceutical ScienceMedicine (miscellaneous)NanoparticleBioengineeringAntiviral AgentsDiffusionNon-competitive inhibitionNanocapsulesMaterials TestingRibavirinHumansGeneral Materials ScienceProdrugschemistry.chemical_classificationGalactoseHep G2 CellsProdrugCarbohydrateVirologyCombinatorial chemistryHepatitis CIn vitroGalactosylated Nanoparticles Hepatic Cell-Targeted Carriers Active Targeting Ribavirin Tripalmitate Hepatitis C.EnzymechemistrySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoDrug deliveryConjugate
researchProduct